Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano E, Krogh V, Munnia A, Tumino R, Polidoro S, Piazza A, Vineis P
Dipartimento di Genetica, Biologia e Biochimica, Università di Torino, 10126, Torino, ISI Foundation, Institute for Scientific Interchange, Villa Gualino, 10133, Torino, Italy.
Carcinogenesis. 2001 Sep;22(9):1437-45. doi: 10.1093/carcin/22.9.1437.
DNA repair genes have an important role in protecting individuals from cancer-causing agents. Polymorphisms in several DNA repair genes have been identified and individuals with non-dramatic reductions in the capacity to repair DNA damage are observed in the population, but the impact of specific genetic variants on repair phenotype and cancer risk has not yet been clarified. In 308 healthy Italian individuals belonging to the prospective European project EPIC, we have investigated the relationship between DNA damage, as measured by (32)P-DNA adduct levels, and three genetic polymorphisms in different repair genes: XRCC1-Arg399Gln (exon 10), XRCC3-Thr241Met (exon 7) and XPD-Lys751Gln (exon 23). DNA adduct levels were measured as relative adduct level (RAL) per 10(9) normal nucleotides by DNA (32)P-post-labelling assay in white blood cells from peripheral blood. Genotyping was performed by PCR-RFLP analysis. The XRCC3-241Met variant was significantly associated with higher DNA adduct levels, whereas XRCC1-399Gln and XPD-751Gln were associated with higher DNA adduct levels only in never-smokers. XRCC3-241Met homozygotes had an average DNA adduct level of 11.44 +/- 1.48 (+/-SE) compared with 7.69 +/- 0.88 in Thr/Met heterozygotes and 6.94 +/- 1.11 in Thr/Thr homozygotes (F = 3.206, P = 0.042). Never-smoking XRCC1-399Gln homozygotes had an average DNA adduct level of 15.60 +/- 5.42 compared with 6.16 +/- 0.97 in Gln/Arg heterozygotes and 6.78 +/- 1.10 in Arg/Arg homozygotes (F = 5.237, P = 0.007). A significant odds ratio (3.81, 95% CI 1.02-14.16) to have DNA adduct levels above median value was observed for XPD-751Gln versus XPD-751Lys never-smoking homozygotes after adjustment for several confounders. These data show that all the analysed polymorphisms could result in deficient DNA repair and suggest a need for further investigation into the possible interactions between these polymorphisms, smoking and other risk factors.
DNA修复基因在保护个体免受致癌物质侵害方面发挥着重要作用。已鉴定出多个DNA修复基因的多态性,并且在人群中观察到DNA损伤修复能力有非显著降低的个体,但特定基因变异对修复表型和癌症风险的影响尚未阐明。在属于前瞻性欧洲项目EPIC的308名健康意大利个体中,我们研究了以(32)P-DNA加合物水平衡量的DNA损伤与不同修复基因中的三种基因多态性之间的关系:XRCC1-Arg399Gln(第10外显子)、XRCC3-Thr241Met(第7外显子)和XPD-Lys751Gln(第23外显子)。通过DNA(32)P后标记法在来自外周血的白细胞中以每10(9)个正常核苷酸的相对加合物水平(RAL)来测量DNA加合物水平。通过PCR-RFLP分析进行基因分型。XRCC3-241Met变异与较高的DNA加合物水平显著相关,而XRCC1-399Gln和XPD-751Gln仅在从不吸烟者中与较高的DNA加合物水平相关。与Thr/Met杂合子的7.69±0.88和Thr/Thr纯合子的6.94±1.11相比,XRCC3-241Met纯合子的平均DNA加合物水平为11.44±1.48(±SE)(F = 3.206,P = 0.042)。从不吸烟的XRCC1-399Gln纯合子的平均DNA加合物水平为15.60±5.42,而Gln/Arg杂合子为6.16±0.97,Arg/Arg纯合子为6.78±1.10(F = 5.237,P = 0.007)。在对多个混杂因素进行调整后,观察到从不吸烟的XPD-751Gln纯合子与XPD-751Lys纯合子相比,DNA加合物水平高于中位数的显著优势比(3.81,95%CI 1.02 - 14.16)。这些数据表明,所有分析的多态性都可能导致DNA修复缺陷,并表明需要进一步研究这些多态性、吸烟和其他风险因素之间可能的相互作用。